Alternatively, the longer time-course (several weeks for tumor angiogenesis, versus several days for embryo angiogenesis) and growing genetic heterogeneity may allow tumors time to compensate for the loss of FN in ways that the developing embryo cannot. This evidence concerns the gene FN1 and neoplasm.